Genus plc (GENSF) has a profit margin of 22.89%, above the Healthcare sector average of 9.48%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for GENSF is 22.89% as of June 2026. That compares with 3.03% in the prior-year period — up 654.7% year over year. That is above the Healthcare sector average of 9.48%. Investors often review this figure alongside Genus plc's historical trend and sector peers before judging valuation or financial health.
Over the past year, GENSF's profit margin moved from 3.03% to 22.89% — a 654.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Genus plc's valuation or profitability profile.
Against Healthcare companies, GENSF currently prints 22.89% for profit margin, while the sector average sits near 9.48%. That is roughly 141.4% above the sector mean. Large gaps often invite a closer look at Genus plc's growth, margins, and balance sheet.
Profit Margin shows how effectively Genus plc converts resources into returns. At 22.89%, GENSF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 3.03% in the prior-year period — up 654.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GENSF's profit margin (22.89%), review year-over-year change from 3.03%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.